Table of contents

Reviews

• Clinical relevance of the new IASLC/ERS/ATS adenocarcinoma classification (6 April, 2013)

  Keith M Kerr
• Lung cancer in never-smokers. Does smoking history matter in the era of molecular diagnostics and targeted therapy? (9 May, 2013)

  Sai-Hong Ignatius Ou
• Challenges and controversies in the diagnosis of mesothelioma: Part 1. Cytology-only diagnosis, biopsies, immunohistochemistry, discrimination between mesothelioma and reactive mesothelial hyperplasia, and biomarkers (27 June, 2013)

  Douglas W Henderson, Glen Reid, Steven C Kao, Nico van Zandwijk, Sonja Klebe
• Challenges and controversies in the diagnosis of malignant mesothelioma: Part 2. Malignant mesothelioma subtypes, pleural synovial sarcoma, molecular and prognostic aspects of mesothelioma, BAP1, aquaporin-1 and microRNA (6 July, 2013)

  Douglas W Henderson, Glen Reid, Steven C Kao, Nico van Zandwijk, Sonja Klebe
• Neuroendocrine tumours—challenges in the diagnosis and classification of pulmonary neuroendocrine tumours (17 May, 2013)

  M A den Bakker, F B J M Thunnissen
• Molecular genetic testing for lung adenocarcinomas: a practical approach to clinically relevant mutations and translocations (25 June, 2013)

  Sanja Dacic
• Fibrosing organising pneumonia (6 July, 2013)

  Brooke Beardsley, Doris Rassl
• Smoking-related interstitial fibrosis (SRIF): pathologic findings and distinction from other chronic fibrosing lung diseases (27 April, 2013)

  Anna-Luise A Katzenstein
• Hypersensitivity pneumonitis: a review and update of histologic findings (23 July, 2013)

  Dianne Grunes, Mary Beth Beasley
• Usual interstitial pneumonia-pattern fibrosis in surgical lung biopsies. Clinical, radiological and histopathological clues to aetiology

  (23 May, 2013)

  Maxwell Smith, Mercedes Dalurzo, Prasad Panse, James Parish, Kevin Leslie
• Cystic lung disease (1 June, 2013)

  Belinda E Clarke